Leqembi (lecanemab-irmb) - Biogen, Eisai
Lecanemab Treatment and 伪-Synuclein Co-Pathology in the Clarity AD CSF Substudy (CTAD 2026) - Sep 26, 2026 - Abstract #OC50; Pres time: Nov 19, 2026; 01:35 PM - 01:50 PM; No abstract available 
https://www.ctad-alzheimer.com/sites/www.ctad-alzheimer.com/files/medias/documents/Preliminary_Program_CTAD26_2409.pdf
 
Kanta HORIE; Pallavi SACHDEV; Han YIN; Steven HERSCH; Lynn KRAMER; Shobha DHADDA; Michael IRIZARRY
 
Sep 26, 2026
 
Prev Next